nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimexolone—NR3C1—urine—urinary bladder cancer	0.104	0.24	CbGeAlD
Rimexolone—SERPINA6—renal system—urinary bladder cancer	0.0579	0.134	CbGeAlD
Rimexolone—Scab—Fluorouracil—urinary bladder cancer	0.0491	0.0864	CcSEcCtD
Rimexolone—SERPINA6—female reproductive system—urinary bladder cancer	0.0464	0.108	CbGeAlD
Rimexolone—NR3C1—prostate gland—urinary bladder cancer	0.0372	0.0863	CbGeAlD
Rimexolone—NR3C1—seminal vesicle—urinary bladder cancer	0.0315	0.073	CbGeAlD
Rimexolone—NR3C1—epithelium—urinary bladder cancer	0.0273	0.0634	CbGeAlD
Rimexolone—Lacrimation—Fluorouracil—urinary bladder cancer	0.0266	0.0467	CcSEcCtD
Rimexolone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.0264	0.0611	CbGeAlD
Rimexolone—NR3C1—renal system—urinary bladder cancer	0.0254	0.0588	CbGeAlD
Rimexolone—NR3C1—urethra—urinary bladder cancer	0.0249	0.0578	CbGeAlD
Rimexolone—NR3C1—female reproductive system—urinary bladder cancer	0.0203	0.0471	CbGeAlD
Rimexolone—Discomfort—Valrubicin—urinary bladder cancer	0.02	0.0352	CcSEcCtD
Rimexolone—NR3C1—vagina—urinary bladder cancer	0.0184	0.0426	CbGeAlD
Rimexolone—Photophobia—Thiotepa—urinary bladder cancer	0.0177	0.0312	CcSEcCtD
Rimexolone—Herpes simplex—Fluorouracil—urinary bladder cancer	0.0169	0.0298	CcSEcCtD
Rimexolone—Lacrimation increased—Fluorouracil—urinary bladder cancer	0.0169	0.0298	CcSEcCtD
Rimexolone—Vision blurred—Mitomycin—urinary bladder cancer	0.0155	0.0272	CcSEcCtD
Rimexolone—Photophobia—Fluorouracil—urinary bladder cancer	0.0147	0.0258	CcSEcCtD
Rimexolone—Discomfort—Mitomycin—urinary bladder cancer	0.0138	0.0243	CcSEcCtD
Rimexolone—Pruritus—Valrubicin—urinary bladder cancer	0.0138	0.0242	CcSEcCtD
Rimexolone—Oedema—Mitomycin—urinary bladder cancer	0.0134	0.0236	CcSEcCtD
Rimexolone—Lacrimation—Epirubicin—urinary bladder cancer	0.0129	0.0227	CcSEcCtD
Rimexolone—Headache—Valrubicin—urinary bladder cancer	0.0122	0.0214	CcSEcCtD
Rimexolone—Lacrimation—Doxorubicin—urinary bladder cancer	0.012	0.021	CcSEcCtD
Rimexolone—NR3C1—lymph node—urinary bladder cancer	0.0119	0.0276	CbGeAlD
Rimexolone—Keratitis—Epirubicin—urinary bladder cancer	0.0117	0.0206	CcSEcCtD
Rimexolone—Keratitis—Doxorubicin—urinary bladder cancer	0.0108	0.0191	CcSEcCtD
Rimexolone—Herpes simplex—Methotrexate—urinary bladder cancer	0.00882	0.0155	CcSEcCtD
Rimexolone—Headache—Mitomycin—urinary bladder cancer	0.00839	0.0148	CcSEcCtD
Rimexolone—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00825	0.0145	CcSEcCtD
Rimexolone—Herpes simplex—Epirubicin—urinary bladder cancer	0.00825	0.0145	CcSEcCtD
Rimexolone—Rhinitis—Gemcitabine—urinary bladder cancer	0.008	0.0141	CcSEcCtD
Rimexolone—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00792	0.0139	CcSEcCtD
Rimexolone—Rhinitis—Fluorouracil—urinary bladder cancer	0.00786	0.0138	CcSEcCtD
Rimexolone—Pharyngitis—Fluorouracil—urinary bladder cancer	0.00778	0.0137	CcSEcCtD
Rimexolone—Vision blurred—Thiotepa—urinary bladder cancer	0.00778	0.0137	CcSEcCtD
Rimexolone—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00763	0.0134	CcSEcCtD
Rimexolone—Herpes simplex—Doxorubicin—urinary bladder cancer	0.00763	0.0134	CcSEcCtD
Rimexolone—Dry eye—Epirubicin—urinary bladder cancer	0.00702	0.0123	CcSEcCtD
Rimexolone—Dry eye—Doxorubicin—urinary bladder cancer	0.0065	0.0114	CcSEcCtD
Rimexolone—Vision blurred—Fluorouracil—urinary bladder cancer	0.00643	0.0113	CcSEcCtD
Rimexolone—Eye pain—Epirubicin—urinary bladder cancer	0.00611	0.0107	CcSEcCtD
Rimexolone—Vision blurred—Cisplatin—urinary bladder cancer	0.0061	0.0107	CcSEcCtD
Rimexolone—Discomfort—Gemcitabine—urinary bladder cancer	0.00584	0.0103	CcSEcCtD
Rimexolone—Dysgeusia—Etoposide—urinary bladder cancer	0.00581	0.0102	CcSEcCtD
Rimexolone—Discomfort—Fluorouracil—urinary bladder cancer	0.00574	0.0101	CcSEcCtD
Rimexolone—Oedema—Gemcitabine—urinary bladder cancer	0.00567	0.00996	CcSEcCtD
Rimexolone—Eye pain—Doxorubicin—urinary bladder cancer	0.00566	0.00995	CcSEcCtD
Rimexolone—Oedema—Fluorouracil—urinary bladder cancer	0.00557	0.0098	CcSEcCtD
Rimexolone—Discomfort—Cisplatin—urinary bladder cancer	0.00544	0.00957	CcSEcCtD
Rimexolone—Hypotension—Gemcitabine—urinary bladder cancer	0.0053	0.00931	CcSEcCtD
Rimexolone—Oedema—Cisplatin—urinary bladder cancer	0.00528	0.00929	CcSEcCtD
Rimexolone—Hypotension—Fluorouracil—urinary bladder cancer	0.00521	0.00915	CcSEcCtD
Rimexolone—Discomfort—Etoposide—urinary bladder cancer	0.00499	0.00877	CcSEcCtD
Rimexolone—Hypotension—Cisplatin—urinary bladder cancer	0.00494	0.00868	CcSEcCtD
Rimexolone—Pruritus—Thiotepa—urinary bladder cancer	0.00477	0.00838	CcSEcCtD
Rimexolone—Hypotension—Etoposide—urinary bladder cancer	0.00452	0.00795	CcSEcCtD
Rimexolone—Headache—Thiotepa—urinary bladder cancer	0.00422	0.00742	CcSEcCtD
Rimexolone—Pharyngitis—Methotrexate—urinary bladder cancer	0.00405	0.00712	CcSEcCtD
Rimexolone—Pruritus—Gemcitabine—urinary bladder cancer	0.00401	0.00705	CcSEcCtD
Rimexolone—Pruritus—Fluorouracil—urinary bladder cancer	0.00394	0.00693	CcSEcCtD
Rimexolone—Rhinitis—Epirubicin—urinary bladder cancer	0.00383	0.00673	CcSEcCtD
Rimexolone—Pharyngitis—Epirubicin—urinary bladder cancer	0.00379	0.00666	CcSEcCtD
Rimexolone—Headache—Gemcitabine—urinary bladder cancer	0.00355	0.00624	CcSEcCtD
Rimexolone—Rhinitis—Doxorubicin—urinary bladder cancer	0.00354	0.00623	CcSEcCtD
Rimexolone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00351	0.00616	CcSEcCtD
Rimexolone—Headache—Fluorouracil—urinary bladder cancer	0.00349	0.00614	CcSEcCtD
Rimexolone—Dysgeusia—Methotrexate—urinary bladder cancer	0.00348	0.00612	CcSEcCtD
Rimexolone—Pruritus—Etoposide—urinary bladder cancer	0.00342	0.00602	CcSEcCtD
Rimexolone—Vision blurred—Methotrexate—urinary bladder cancer	0.00335	0.00588	CcSEcCtD
Rimexolone—Dysgeusia—Epirubicin—urinary bladder cancer	0.00325	0.00572	CcSEcCtD
Rimexolone—Vision blurred—Epirubicin—urinary bladder cancer	0.00313	0.00551	CcSEcCtD
Rimexolone—Headache—Etoposide—urinary bladder cancer	0.00303	0.00533	CcSEcCtD
Rimexolone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00301	0.0053	CcSEcCtD
Rimexolone—Discomfort—Methotrexate—urinary bladder cancer	0.00299	0.00525	CcSEcCtD
Rimexolone—Vision blurred—Doxorubicin—urinary bladder cancer	0.0029	0.0051	CcSEcCtD
Rimexolone—Discomfort—Epirubicin—urinary bladder cancer	0.0028	0.00492	CcSEcCtD
Rimexolone—Oedema—Epirubicin—urinary bladder cancer	0.00271	0.00477	CcSEcCtD
Rimexolone—Hypotension—Methotrexate—urinary bladder cancer	0.00271	0.00476	CcSEcCtD
Rimexolone—Discomfort—Doxorubicin—urinary bladder cancer	0.00259	0.00455	CcSEcCtD
Rimexolone—Hypotension—Epirubicin—urinary bladder cancer	0.00253	0.00446	CcSEcCtD
Rimexolone—Oedema—Doxorubicin—urinary bladder cancer	0.00251	0.00441	CcSEcCtD
Rimexolone—Hypotension—Doxorubicin—urinary bladder cancer	0.00235	0.00412	CcSEcCtD
Rimexolone—Pruritus—Methotrexate—urinary bladder cancer	0.00205	0.00361	CcSEcCtD
Rimexolone—Pruritus—Epirubicin—urinary bladder cancer	0.00192	0.00337	CcSEcCtD
Rimexolone—Headache—Methotrexate—urinary bladder cancer	0.00182	0.00319	CcSEcCtD
Rimexolone—Pruritus—Doxorubicin—urinary bladder cancer	0.00178	0.00312	CcSEcCtD
Rimexolone—Headache—Epirubicin—urinary bladder cancer	0.0017	0.00299	CcSEcCtD
Rimexolone—Headache—Doxorubicin—urinary bladder cancer	0.00157	0.00276	CcSEcCtD
